Free Trial

Global Medical REIT (XRN) Stock Price, News & Analysis

Global Medical REIT logo
$32.21 -3.38 (-9.49%)
Closing price 05/7/2026 03:59 PM Eastern
Extended Trading
$32.30 +0.09 (+0.29%)
As of 06:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Global Medical REIT Stock (NYSE:XRN)

Advanced

Key Stats

Today's Range
$29.05
$32.90
50-Day Range
$32.21
$36.37
52-Week Range
$29.05
$39.93
Volume
751,567 shs
Average Volume
82,221 shs
Market Capitalization
$426.34 million
P/E Ratio
N/A
Dividend Yield
9.31%
Price Target
$39.67
Consensus Rating
Moderate Buy

Company Overview

Global Medical REIT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
48th Percentile Overall Score

XRN MarketRank™: 

Global Medical REIT scored higher than 48% of companies evaluated by MarketBeat, and ranked 663rd out of 878 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Global Medical REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 2 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Global Medical REIT has a consensus price target of $39.67, representing about 23.1% upside from its current price of $32.21.

  • Amount of Analyst Coverage

    Global Medical REIT has only been the subject of 2 research reports in the past 90 days.

  • Read more about Global Medical REIT's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Global Medical REIT is -29.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Global Medical REIT is -29.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Global Medical REIT has a P/B Ratio of 1.06. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for XRN.
  • Dividend Leadership

    Global Medical REIT is a leading dividend payer. It pays a dividend yield of 8.48%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Global Medical REIT does not have a long track record of dividend growth.

  • Read more about Global Medical REIT's dividend.
  • News Sentiment

    Global Medical REIT has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Global Medical REIT this week, compared to 1 article on an average week.
  • Search Interest

    Only 9 people have searched for XRN on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added Global Medical REIT to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Global Medical REIT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    8.90% of the stock of Global Medical REIT is held by insiders.

  • Percentage Held by Institutions

    57.52% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Global Medical REIT's insider trading history.
Receive XRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XRN Stock News Headlines

I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
See More Headlines

XRN Stock Analysis - Frequently Asked Questions

Global Medical REIT's stock was trading at $33.67 at the beginning of 2026. Since then, XRN shares have decreased by 4.3% and is now trading at $32.2130.

Global Medical REIT Inc. (NYSE:XRN) issued its earnings results on Tuesday, November, 4th. The company reported $1.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.07. The firm had revenue of $37.23 million for the quarter, compared to analyst estimates of $38.15 million. Global Medical REIT had a negative net margin of 6.06% and a negative trailing twelve-month return on equity of 2.14%.
Read the conference call transcript
.

Global Medical REIT's stock reverse split before market open on Monday, September 22nd 2025.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, September 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Global Medical REIT's Board of Directors authorized a stock buyback plan on Wednesday, August 13th 2025, which permits the company to buy back $50,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 11.1% of its shares through open market purchases. Shares buyback plans are usually a sign that the company's leadership believes its stock is undervalued.

Shares of XRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Medical REIT investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), AUO (AUOTY), The RMR Group (RMR), Waste Connections (WCN), Voyager Therapeutics (VYGR) and Humana (HUM).

Company Calendar

Last Earnings
11/04/2025
Record date for 5/15 Dividend
4/20/2026
Ex-Dividend for 5/15 Dividend
4/20/2026
Today
5/08/2026
Dividend Payable
5/15/2026
Record date for 6/12 Dividend
5/20/2026
Ex-Dividend for 6/12 Dividend
5/20/2026
Dividend Payable
6/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Finance
Industry
REIT - EQTY TRUST - OTHER
Sub-Industry
Trading
Current Symbol
NYSE:XRN
Previous Symbol
NYSE:GMRE
CIK
1533615
Fax
N/A
Employees
30
Year Founded
2014

Price Target and Rating

High Price Target
$41.00
Low Price Target
$38.00
Potential Upside/Downside
+23.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.11)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.84 million
Net Margins
-6.06%
Pretax Margin
-4.64%
Return on Equity
-2.14%
Return on Assets
-0.72%

Debt

Debt-to-Equity Ratio
1.62
Current Ratio
0.61
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$151.11 million
Price / Sales
2.82
Cash Flow
$3.77 per share
Price / Cash Flow
8.54
Book Value
$30.28 per share
Price / Book
1.06

Miscellaneous

Outstanding Shares
13,235,000
Free Float
12,057,000
Market Cap
$426.34 million
Optionable
Optionable
Beta
1.11

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:XRN) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners